All Stories

  1. Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease

    Article • Postgraduate Medicine, November 2018, Taylor & Francis

    Michael S. Kelly, Dr Ashley M Huntsberry

  2. Evolving Role of Non-Statin Therapy for the Management of Dyslipidemia and Cardiovascular Risk Reduction: Past, Present, and Future

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, January 2018, Wiley

    Dr Dave L Dixon, Michael S. Kelly

  3. Pharmacologic approaches for the management of patients with moderately elevated triglycerides (150–499 mg/dL)

    Article • Journal of Clinical Lipidology, July 2017, Elsevier

    Dr Dave L Dixon, Michael S. Kelly

  4. Effects of Sodium‐Glucose Cotransporter 2 Inhibitors on 24‐Hour Ambulatory Blood Pressure: A Systematic Review and Meta‐Analysis

    Article • Journal of the American Heart Association, May 2017, Wolters Kluwer Health

    Roy Brown, Dr Dave L Dixon, Michael S. Kelly

  5. Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60–79 years before and after Eighth Joint National Committee recommendations

    Article • Therapeutic Advances in Cardiovascular Disease, February 2017, SAGE Publications

    Michael S. Kelly

  6. Effectiveness of Pharmacist-Led Amiodarone Monitoring Services on Improving Adherence to Amiodarone Monitoring Recommendations: A Systematic Review

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, February 2016, Wiley

    Dr Dave L Dixon, Roy Brown, Michael S. Kelly

  7. Concordance of Pharmacist Assessment of Medication Nonadherence With a Self-Report Medication Adherence Scale

    Article • Journal of Pharmacy Practice, October 2014, SAGE Publications

    Michael S. Kelly